
Life Sciences Tools Stocks to Own in 2026: 7 Names to Know
A seven-stock countdown spans genomics, proteomics, diagnostics, analytical tools, bioprocessing, and broad laboratory platforms.
Every article, report, and earnings note where WAT appears.

A seven-stock countdown spans genomics, proteomics, diagnostics, analytical tools, bioprocessing, and broad laboratory platforms.

Waters is leaning into a larger life-science and diagnostics platform after its BD Biosciences and Diagnostic Solutions acquisition. Strong Q1 growth and raised guidance support a Buy, but leverage and a premium valuation keep the setup balanced.

Waters Corporation (WAT) climbs after-hours after a strong first-quarter report beat revenue guidance and lifted full-year profit outlook. The move reflects investor confidence in the company’s newly expanded business after its $18.8 billion BD biosciences and diagnostics deal.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate WAT ReportCancel anytime